As shown in Figure 3B, the TNBCvax group (a combination of all three antigens) and the individual IGF-1R, HIF-1α, and TOP2A vaccination groups showed significantly reduced tumor growth rates compared to the CpG control group. This evidence concerns the gene IGF1R and neoplasm.